PRESS RELEASE published on 02/06/2026 at 07:30, 7 months 1 day ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 7 months 10 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
BRIEF published on 01/28/2026 at 07:48, 7 months 10 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 01/28/2026 at 07:43, 7 months 10 days ago Informations privilégiées / Autres communiqués Sensorion annonce un financement de 60 millions d’euros avec Sanofi et d'autres investisseurs pour développer ses thérapies géniques. Trésorerie prévue jusqu'à mi-2027 Financement Trésorerie Thérapie Génique Sanofi Sensorion
PRESS RELEASE published on 01/28/2026 at 07:43, 7 months 10 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 8 months 19 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
BRIEF published on 12/19/2025 at 07:35, 8 months 19 days ago Sensorion présentera ses services lors de la conférence JP Morgan Healthcare. Biotechnologie Thérapie Génique JP Morgan Perte Auditive SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 8 months 19 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
PRESS RELEASE published on 12/19/2025 at 07:30, 8 months 19 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 11 months 20 days ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
Published on 09/08/2026 at 01:45, 2 hours 16 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 2 days 23 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 4 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 5 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 5 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 8 hours 42 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 9 hours 1 minute ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 9 hours 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 10 hours 1 minute ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 10 hours 16 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 9 hours 1 minute ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 9 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 9 hours 56 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 9 hours 56 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
